Directed (R)- or (S)-Selective Dynamic Kinetic Enzymatic Hydrolysis
Ͼ99%ee. 1H NMR (400 MHz, CDCl3): δ = 2.98–3.19 (m, 2 H,
CH2–CH2–NH), 3.35–3.53 (m, 1 H, CH2–CHH–NH), 3.53–3.70
(m, 1 H, CH2–CHH–NH), 4.88–5.05 (s, 1 H, Ar–CH–NH), 7.21–
7.63 (m, 4 H, Ar) ppm. 13C NMR (100.62 MHz, CDCl3) δ = 25.0,
40.3, 59.0, 127.4, 128.3, 128.6, 128.8, 129.1, 132.2, 172.4 ppm.
C10H11NO2 (177.20): calcd. C 67.78, H 6.26, N 7.90; found C
67.71, H 6.38, N 7.72.
Acknowledgments
The Hungarian authors acknowledge the receipt of grants from
the Hungarian Scientific Research Fund (OTKA) (K 71938 and T
049407). T.A.P. is grateful for a fellowship awarded by the Center
for International Mobility (CIMO) in Finland.
(R)-Selective Gram-Scale DKR of (؎)-2b: Compound (Ϯ)-2b
(0.50 g, 1.88 mmol) was transformed by the procedure described
above in an aqueous solution of NH4OAc (0.072 g, 0.94 mmol,
8.7 mL) with EtOH (0.19 mL), at 25 °C, with the aid of CAL-B
(1.00 g, ca. 100 mgmL–1) at constant pH 8.5 (adjusted from time
to time with NH4OH 0.5 ). After 7 h (conv. Ն99%), the reaction
was worked up. Compound (R)-2a (0.38 g, 1.60 mmol, 85% yield)
was isolated with 92%ee; it was recrystallised from H2O/EtOH
[1] J. D. Scott, R. M. Williams, Chem. Rev. 2002, 102, 1669–1730.
[2] a) C. van Kesteren, M. M. M. de Vooght, L. Lopez-Lazaro,
R. A. A. Mathot, J. H. M. Schellens, J. M. Jimeno, J. H. Be-
ijnen, Anti-Cancer Drugs 2003, 14, 487–502; b) N. J. Carter,
S. J. Keam, Drugs 2007, 67, 2257–2276.
[3] D. R. Dalton in Studies in Organic Chemistry (Ed.: P. G. Gass-
man), Marcel Dekker Inc., New York, 1979, vol. 7, pp. 184–
190.
[4] a) M. Naoi, W. Maruyama, P. Dostert, K. Kohda, T. Kaiya,
Neurosci. Lett. 1996, 212, 183–186; b) B. E. Tóth, I. Bodnár,
K. G. Homicskó, F. Fülöp, M. I. K. Fekete, G. M. Nagy, Neur-
otoxicol. Teratol. 2002, 24, 655–666.
[5] A. Hofmeister, M. Schudok, H. Matter, K. Breitschopf, A. Ug-
olini, PCT Int. Appl. WO 2006002763, 2006.
[6] a) Y. Gao, X. Liu, W. Liu, Y. Qi, X. Liu, Y. Zhou, R. Wang,
Bioorg. Med. Chem. Lett. 2006, 16, 3688–3692; b) Y. Moro-
hashi, T. Kan, Y. Tominari, H. Fuwa, Y. Okamura, N. Watan-
abe, C. Sato, H. Natsugari, T. Fukuyama, T. Iwatsubo, T. Tom-
ita, J. Biol. Chem. 2006, 281, 14670–14676; c) P. Örtqvist, S. D.
Peterson, E. Åkerblom, T. Gossas, Y. A. Sabnis, R. Fransson,
G. Lindeberg, U. H. Danielson, A. Karlén, A. Sandström,
Bioorg. Med. Chem. 2007, 15, 1448–1474.
[7] a) S. E. Gibson, N. Guillo, J. O. Jones, I. M. Buck, S. B. Kal-
indjian, S. Roberts, M. J. Tozer, Eur. J. Med. Chem. 2002, 37,
379–389; b) S. E. Gibson, N. Guillo, M. J. Tozer, Tetrahedron
1999, 55, 585–615.
1
(1:1). [α]2D5 = –63 (c = 0.30, H2O). M.p. 266–268 °C. Ն99%ee. H
NMR (400 MHz, CDCl3): δ = 2.95–3.15 (m, 2 H, CH2–CH2–NH),
3.42–3.57 (m, 1 H, CH2–CHH–NH), 3.57–3.71 (m, 1 H, CH2–
CHH–NH), 3.77–3.92 (s, 3 H, CH3O–Ar), 3.92–4.03 (s, 3 H,
CH3O–Ar), 4.88–4.99 (s, 1 H, Ar–CH–NH), 6.88–7.01 (s, 1 H, Ar),
7.17–7.28 (s, 1 H, Ar) ppm. 13C NMR (100.62 MHz, CDCl3) δ =
24.5, 40.3, 56.1, 56.2, 58.6, 111.1, 112.0, 120.3, 124.9, 146.9, 148.0,
172.1 ppm. C12H15NO4 (237.25): calcd. C 60.75, H 6.37, N 5.90;
found C 60.58, H 6.51, N 5.81.
(S)-Selective Gram-Scale DKR of (؎)-2b: Compound (Ϯ)-2b
(0.50 g, 1.88 mmol) was transformed by the procedure described
above in an aqueous solution of NH4OAc (0.072 g, 0.94 mmol,
8.7 mL) with EtOH (0.19 mL) at 3 °C, with Alcalase (0.76 g, ca.
80 mgmL–1) at constant pH 8.5. After 3 d (conv. Ն99%), the reac-
tion was worked up. Compound (S)-2a (0.41 g, 1.73 mmol, 92%
yield) was isolated with 93%ee; it was recrystallised from H2O/
EtOH (1:1). [α]2D5 = +62 (c = 0.30, H2O). M.p. 265–267 °C.
Ն99%ee. The 1H NMR (400 MHz, H2O) data are similar to those
for (R)-2a. C12H15NO4 (237.25): calcd. C 60.75, H 6.37, N 5.90;
found C 60.62, H 6.46, N 5.83.
[8] K. W. Bentley, Nat. Prod. Rep. 2001, 18, 148–170.
[9] A. Mjalli, D. Jones, D. R. Gohimmukkula, PCT Int. Appl. WO
2006099379, 2006.
[10] a) S. Bajusz, L. Mohai, A. Fehér, J. Lavich, G. Széll, B.
Véghelyi, PCT Int. Appl. WO 199312091, 1993; b) O. Sieck, S.
Schaller, S. Grimme, J. Liebscher, Synlett 2003, 337–340.
[11] a) M. Ziółkowski, Z. Czarnoczki, A. Leniewski, J. K. Maurin,
Tetrahedron: Asymmetry 1999, 10, 3371–3380; b) N. Sasamoto,
C. Dubs, Y. Hamashima, M. Sodeoka, J. Am. Chem. Soc. 2006,
128, 14010–14011; c) T. Kanemitsu, Y. Yamashita, K. Nagata,
T. Itoh, Synlett 2006, 10, 1595–1597.
[12] a) T. A. Paál, E. Forró, A. Liljeblad, L. T. Kanerva, F. Fülöp,
Tetrahedron: Asymmetry 2007, 18, 1428–1433; b) I. S. Gill, E.
Kick, K. Richlin-Zack, W. Yang, Y. Wang, R. N. Patel, Tetra-
hedron: Asymmetry 2007, 18, 2147–2154.
[13] H. Pellissier, Tetrahedron 2008, 64, 1563–1601.
[14] a) J. A. Chaplin, M. D. Levin, B. Morgan, N. Farid, J. Li, Z.
Zhu, J. McQuaid, L. W. Nicholson, C. A. Rand, M. J. Burk,
Tetrahedron: Asymmetry 2004, 15, 2793–2796; b) D. Arosio,
A. Caligiuri, P. D’Arrigoa, G. Pedrocchi-Fantoni, C. Rossi, C.
Saraceno, S. Servi, D. Tessaro, Adv. Synth. Catal. 2007, 349,
1345–1348.
Assignment of the Absolute Configurations of (R)-2a and (S)-2a
(R)-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methanol
[(R)-Calycotomine, (R)-3]: To a suspension of LiAlH4 (0.19 g,
5.01 mmol) in dry THF (4 mL) at 25 °C was added (R)-2a (0.20 g,
0.84 mmol, 95%ee) in portions. The mixture was heated at reflux
for 6 h under vigorous stirring and thereafter cooled to 25 °C. The
excess amount of LiAlH4 was decomposed by adding H2O
(0.36 mL) in THF (5.0 mL) in portions, and stirring the mixture
for 30 min. The insoluble residue was filtered off and washed re-
peatedly with THF. The filtrate was dried with Na2SO4, and the
solvent was evaporated. The residue was recrystallised from tolu-
ene. Compound (R)-3 (0.075 g, 0.34 mmol, 40% yield) was ob-
tained as white crystalline powder after filtration. [α]2D5 = –33 (c =
0.2, H2O), ref.[23] [α]2D5 = +37.9 (c = 0.2, H2O) (for (S)-calycotom-
ine). M.p. 146–148 °C, ref.[11c] m.p. 138 °C, ref.[23] m.p. 140 °C.
91%ee. 1H NMR (400 MHz, CDCl3): δ = 1.33–2.06 (br. s, 2 H,
OH, NH), 2.58–2.77 (m, 2 H, CH2–CH2–NH), 2.97–3.15 (m, 2 H,
CH2–CH2–NH), 3.53–3.69 (m, 1 H, CH–CH2–OH), 3.69–3.79 (dd,
J = 10.7 Hz, J = 4.3 Hz, 1 H, CH–CHH–OH), 3.79–3.84 (s, 3 H,
CH3O–Ar), 3.84–3.90 (s, 3 H, CH3O–Ar), 3.90–4.04 (dd, J =
9.2 Hz, J = 4.3 Hz, 1 H, CH–CHH–OH), 6.50–6.58 (s, 1 H, Ar),
6.58–6.67 (s, 1 H, Ar) ppm. 13C NMR (100.62 MHz, CDCl3) δ =
29.8, 39.5, 56.5, 56.7, 64.8, 109.9, 112.7, 127.8, 128.4, 148.2,
148.5 ppm. C12H17NO3 (223.27): calcd. C 64.55, H 7.67, N 6.27;
found C 64.37, H 7.81, N 6.11.
[15] Z. Zalán, T. A. Martinek, L. Lázár, R. Sillanpää, F. Fülöp,
Tetrahedron 2006, 62, 2883–2891.
[16] a) J. M. Palomo, G. Fernández-Lorente, C. Mateo, M. Fuentes,
R. Fernández-Lafuente, J. M. Guisán, Tetrahedron: Asymmetry
2002, 13, 1337–1345; b) R. Torres, C. Ortiz, B. C. C. Pessela,
J. M. Palomo, C. Mateo, J. M. Guisán, R. Fernández-Lafuente,
Enzyme Microb. Technol. 2006, 39, 167–171.
[17] O. Kirk, M. W. Christensen, Org. Process Res. Dev. 2002, 6,
446–451.
[18] a) H. Zhao, J. Mol. Catal. B: Enzym. 2005, 37, 16–25; b) E. M.
Bowers, L. O. Ragland, L. D. Byers, Biochim. Biophys. Acta
2007, 1774, 1500–1507.
[19] J. C. Warren, S. G. Cheatum, Biochemistry 1966, 5, 1702.
Eur. J. Org. Chem. 2008, 5269–5276
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5275